nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA14—Imatinib—hematologic cancer	0.0847	0.135	CbGbCtD
Zoledronate—CA14—Nilotinib—hematologic cancer	0.077	0.123	CbGbCtD
Zoledronate—ABCC1—Idarubicin—hematologic cancer	0.0638	0.102	CbGbCtD
Zoledronate—CA12—Imatinib—hematologic cancer	0.0602	0.0958	CbGbCtD
Zoledronate—CA12—Nilotinib—hematologic cancer	0.0547	0.0871	CbGbCtD
Zoledronate—CA2—Imatinib—hematologic cancer	0.0487	0.0775	CbGbCtD
Zoledronate—ABCC1—Daunorubicin—hematologic cancer	0.0451	0.0718	CbGbCtD
Zoledronate—CA2—Nilotinib—hematologic cancer	0.0442	0.0704	CbGbCtD
Zoledronate—ABCC1—Mitoxantrone—hematologic cancer	0.0274	0.0436	CbGbCtD
Zoledronate—ABCC1—Epirubicin—hematologic cancer	0.0222	0.0353	CbGbCtD
Zoledronate—ABCC1—Irinotecan—hematologic cancer	0.0216	0.0344	CbGbCtD
Zoledronate—ABCC1—Vinblastine—hematologic cancer	0.0192	0.0306	CbGbCtD
Zoledronate—ABCC1—Vincristine—hematologic cancer	0.0189	0.03	CbGbCtD
Zoledronate—ABCC1—Etoposide—hematologic cancer	0.0173	0.0275	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—hematologic cancer	0.0118	0.0188	CbGbCtD
Zoledronate—ABCC1—Methotrexate—hematologic cancer	0.0114	0.0182	CbGbCtD
Zoledronate—GGPS1—hematopoietic system—hematologic cancer	0.00509	0.118	CbGeAlD
Zoledronate—GGPS1—gonad—hematologic cancer	0.00387	0.0897	CbGeAlD
Zoledronate—GGPS1—blood—hematologic cancer	0.00337	0.0781	CbGeAlD
Zoledronate—GGPS1—bone marrow—hematologic cancer	0.00326	0.0756	CbGeAlD
Zoledronate—GGPS1—lung—hematologic cancer	0.00296	0.0685	CbGeAlD
Zoledronate—GGPS1—testis—hematologic cancer	0.00279	0.0646	CbGeAlD
Zoledronate—FDPS—hematopoietic system—hematologic cancer	0.00235	0.0544	CbGeAlD
Zoledronate—GGPS1—lymph node—hematologic cancer	0.00202	0.0469	CbGeAlD
Zoledronate—FDPS—gonad—hematologic cancer	0.00178	0.0413	CbGeAlD
Zoledronate—FDPS—blood—hematologic cancer	0.00155	0.036	CbGeAlD
Zoledronate—FDPS—bone marrow—hematologic cancer	0.0015	0.0349	CbGeAlD
Zoledronate—CA12—lung—hematologic cancer	0.00138	0.0319	CbGeAlD
Zoledronate—FDPS—lung—hematologic cancer	0.00136	0.0316	CbGeAlD
Zoledronate—FDPS—testis—hematologic cancer	0.00129	0.0298	CbGeAlD
Zoledronate—CA2—hematopoietic system—hematologic cancer	0.00122	0.0282	CbGeAlD
Zoledronate—FDPS—lymph node—hematologic cancer	0.000932	0.0216	CbGeAlD
Zoledronate—ABCC1—blood—hematologic cancer	0.000902	0.0209	CbGeAlD
Zoledronate—CA2—blood—hematologic cancer	0.000807	0.0187	CbGeAlD
Zoledronate—ABCC1—lung—hematologic cancer	0.000791	0.0183	CbGeAlD
Zoledronate—CA2—bone marrow—hematologic cancer	0.000781	0.0181	CbGeAlD
Zoledronate—ABCC1—testis—hematologic cancer	0.000747	0.0173	CbGeAlD
Zoledronate—CA2—lung—hematologic cancer	0.000707	0.0164	CbGeAlD
Zoledronate—CA2—testis—hematologic cancer	0.000667	0.0155	CbGeAlD
Zoledronate—ABCC1—lymph node—hematologic cancer	0.000541	0.0125	CbGeAlD
Zoledronate—CA2—lymph node—hematologic cancer	0.000484	0.0112	CbGeAlD
Zoledronate—FDPS—Metabolism—NQO1—hematologic cancer	3.18e-05	0.000702	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD44—hematologic cancer	3.18e-05	0.000702	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.15e-05	0.000696	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NUP98—hematologic cancer	3.14e-05	0.000694	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.12e-05	0.000691	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.11e-05	0.000688	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NQO1—hematologic cancer	3.06e-05	0.000677	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD44—hematologic cancer	3.06e-05	0.000677	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.06e-05	0.000677	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ADCY7—hematologic cancer	3.04e-05	0.000673	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOA3—hematologic cancer	3.04e-05	0.000673	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTP1—hematologic cancer	3.03e-05	0.00067	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NUP214—hematologic cancer	3.02e-05	0.000669	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYCS—hematologic cancer	3e-05	0.000665	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.99e-05	0.000662	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HSP90AA1—hematologic cancer	2.99e-05	0.00066	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTR—hematologic cancer	2.96e-05	0.000655	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCG2—hematologic cancer	2.96e-05	0.000655	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CDA—hematologic cancer	2.94e-05	0.000649	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ENO2—hematologic cancer	2.9e-05	0.000642	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYCS—hematologic cancer	2.9e-05	0.000641	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HSP90AA1—hematologic cancer	2.88e-05	0.000637	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCB1—hematologic cancer	2.87e-05	0.000634	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PC—hematologic cancer	2.83e-05	0.000625	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTT1—hematologic cancer	2.82e-05	0.000623	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTEN—hematologic cancer	2.8e-05	0.00062	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTM1—hematologic cancer	2.78e-05	0.000616	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NCOR1—hematologic cancer	2.78e-05	0.000616	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SDC1—hematologic cancer	2.75e-05	0.000609	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GBA—hematologic cancer	2.73e-05	0.000604	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC35B2—hematologic cancer	2.73e-05	0.000604	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.73e-05	0.000603	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.69e-05	0.000594	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—EP300—hematologic cancer	2.67e-05	0.000591	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTP1—hematologic cancer	2.65e-05	0.000586	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPLP1—hematologic cancer	2.6e-05	0.000576	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SNCA—hematologic cancer	2.6e-05	0.000576	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AGRN—hematologic cancer	2.6e-05	0.000576	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.56e-05	0.000567	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—hematologic cancer	2.55e-05	0.000565	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LEF1—hematologic cancer	2.51e-05	0.000556	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCB1—hematologic cancer	2.51e-05	0.000554	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTAP—hematologic cancer	2.5e-05	0.000552	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HMMR—hematologic cancer	2.47e-05	0.000546	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—hematologic cancer	2.46e-05	0.000544	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—hematologic cancer	2.43e-05	0.000538	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NCOR1—hematologic cancer	2.43e-05	0.000538	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—hematologic cancer	2.42e-05	0.000535	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTM1—hematologic cancer	2.35e-05	0.000519	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NCOR1—hematologic cancer	2.35e-05	0.000519	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD44—hematologic cancer	2.34e-05	0.000518	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NQO1—hematologic cancer	2.34e-05	0.000518	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ELL—hematologic cancer	2.32e-05	0.000514	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.29e-05	0.000506	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ACP5—hematologic cancer	2.26e-05	0.0005	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCOR2—hematologic cancer	2.23e-05	0.000493	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FHL2—hematologic cancer	2.22e-05	0.000492	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYCS—hematologic cancer	2.21e-05	0.00049	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HSP90AA1—hematologic cancer	2.2e-05	0.000487	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGRN—hematologic cancer	2.18e-05	0.000483	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—hematologic cancer	2.15e-05	0.000476	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IDH1—hematologic cancer	2.12e-05	0.00047	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GSTO1—hematologic cancer	2.1e-05	0.000464	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—hematologic cancer	2.07e-05	0.000459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMMR—hematologic cancer	2.07e-05	0.000457	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH2—hematologic cancer	2.07e-05	0.000457	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—hematologic cancer	2.07e-05	0.000457	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AGO2—hematologic cancer	2.05e-05	0.000454	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HDAC9—hematologic cancer	2.03e-05	0.00045	CbGpPWpGaD
Zoledronate—ABCC1—Disease—H3F3B—hematologic cancer	2.01e-05	0.000445	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—hematologic cancer	1.98e-05	0.000437	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—hematologic cancer	1.95e-05	0.000432	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.95e-05	0.000431	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ARNTL—hematologic cancer	1.94e-05	0.00043	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NPM1—hematologic cancer	1.94e-05	0.000429	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CREBBP—hematologic cancer	1.92e-05	0.000424	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.91e-05	0.000422	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.9e-05	0.000419	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA9—hematologic cancer	1.89e-05	0.000418	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACP5—hematologic cancer	1.89e-05	0.000418	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOR2—hematologic cancer	1.87e-05	0.000413	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF19—hematologic cancer	1.86e-05	0.000411	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—hematologic cancer	1.85e-05	0.000409	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS14—hematologic cancer	1.84e-05	0.000407	CbGpPWpGaD
Zoledronate—ABCC1—Disease—DKK1—hematologic cancer	1.83e-05	0.000404	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—hematologic cancer	1.82e-05	0.000402	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT5B—hematologic cancer	1.81e-05	0.000401	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NUP98—hematologic cancer	1.81e-05	0.000401	CbGpPWpGaD
Zoledronate—Ill-defined disorder—Methotrexate—hematologic cancer	1.81e-05	6.4e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CG—hematologic cancer	1.81e-05	0.0004	CbGpPWpGaD
Zoledronate—Anaemia—Methotrexate—hematologic cancer	1.8e-05	6.37e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Dexamethasone—hematologic cancer	1.8e-05	6.37e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Betamethasone—hematologic cancer	1.8e-05	6.37e-05	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—hematologic cancer	1.8e-05	6.36e-05	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—hematologic cancer	1.8e-05	6.36e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—GSTM1—hematologic cancer	1.79e-05	0.000397	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—hematologic cancer	1.79e-05	0.000397	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOR1—hematologic cancer	1.79e-05	0.000397	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Betamethasone—hematologic cancer	1.79e-05	6.32e-05	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.79e-05	6.32e-05	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—hematologic cancer	1.79e-05	6.32e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—IDH1—hematologic cancer	1.78e-05	0.000393	CbGpPWpGaD
Zoledronate—Hypersensitivity—Triamcinolone—hematologic cancer	1.78e-05	6.28e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—CST3—hematologic cancer	1.77e-05	0.000392	CbGpPWpGaD
Zoledronate—Back pain—Epirubicin—hematologic cancer	1.77e-05	6.24e-05	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—hematologic cancer	1.76e-05	6.22e-05	CcSEcCtD
Zoledronate—Malaise—Methotrexate—hematologic cancer	1.76e-05	6.22e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—ADCY7—hematologic cancer	1.76e-05	0.000389	CbGpPWpGaD
Zoledronate—Dizziness—Etoposide—hematologic cancer	1.76e-05	6.21e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTO1—hematologic cancer	1.76e-05	0.000389	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCC3—hematologic cancer	1.76e-05	0.000389	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TXN—hematologic cancer	1.76e-05	0.000389	CbGpPWpGaD
Zoledronate—Muscle spasms—Epirubicin—hematologic cancer	1.76e-05	6.2e-05	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—hematologic cancer	1.75e-05	6.19e-05	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—hematologic cancer	1.75e-05	6.19e-05	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—hematologic cancer	1.75e-05	6.18e-05	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—hematologic cancer	1.75e-05	6.17e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—NUP214—hematologic cancer	1.75e-05	0.000386	CbGpPWpGaD
Zoledronate—Chills—Doxorubicin—hematologic cancer	1.74e-05	6.15e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CG—hematologic cancer	1.74e-05	0.000385	CbGpPWpGaD
Zoledronate—Urticaria—Betamethasone—hematologic cancer	1.74e-05	6.14e-05	CcSEcCtD
Zoledronate—Urticaria—Dexamethasone—hematologic cancer	1.74e-05	6.14e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.74e-05	6.13e-05	CcSEcCtD
Zoledronate—Dizziness—Prednisolone—hematologic cancer	1.74e-05	6.13e-05	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—hematologic cancer	1.74e-05	6.13e-05	CcSEcCtD
Zoledronate—Asthenia—Triamcinolone—hematologic cancer	1.73e-05	6.11e-05	CcSEcCtD
Zoledronate—Body temperature increased—Betamethasone—hematologic cancer	1.73e-05	6.11e-05	CcSEcCtD
Zoledronate—Abdominal pain—Betamethasone—hematologic cancer	1.73e-05	6.11e-05	CcSEcCtD
Zoledronate—Body temperature increased—Dexamethasone—hematologic cancer	1.73e-05	6.11e-05	CcSEcCtD
Zoledronate—Abdominal pain—Dexamethasone—hematologic cancer	1.73e-05	6.11e-05	CcSEcCtD
Zoledronate—Nausea—Cisplatin—hematologic cancer	1.73e-05	6.09e-05	CcSEcCtD
Zoledronate—Insomnia—Prednisone—hematologic cancer	1.72e-05	6.09e-05	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—hematologic cancer	1.72e-05	6.08e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SPHK1—hematologic cancer	1.72e-05	0.000381	CbGpPWpGaD
Zoledronate—Alopecia—Doxorubicin—hematologic cancer	1.72e-05	6.06e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—PIK3R1—hematologic cancer	1.72e-05	0.00038	CbGpPWpGaD
Zoledronate—Paraesthesia—Prednisone—hematologic cancer	1.71e-05	6.04e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—MTR—hematologic cancer	1.71e-05	0.000379	CbGpPWpGaD
Zoledronate—ABCC1—Disease—XIAP—hematologic cancer	1.71e-05	0.000379	CbGpPWpGaD
Zoledronate—Pruritus—Triamcinolone—hematologic cancer	1.71e-05	6.03e-05	CcSEcCtD
Zoledronate—Cough—Methotrexate—hematologic cancer	1.7e-05	6.02e-05	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—hematologic cancer	1.7e-05	6.01e-05	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—hematologic cancer	1.7e-05	5.99e-05	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—hematologic cancer	1.69e-05	5.97e-05	CcSEcCtD
Zoledronate—Vomiting—Etoposide—hematologic cancer	1.69e-05	5.97e-05	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—hematologic cancer	1.69e-05	5.97e-05	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—hematologic cancer	1.69e-05	5.97e-05	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—hematologic cancer	1.69e-05	5.96e-05	CcSEcCtD
Zoledronate—Agitation—Epirubicin—hematologic cancer	1.68e-05	5.93e-05	CcSEcCtD
Zoledronate—Dyspepsia—Prednisone—hematologic cancer	1.68e-05	5.93e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—ENO2—hematologic cancer	1.68e-05	0.000371	CbGpPWpGaD
Zoledronate—Rash—Etoposide—hematologic cancer	1.68e-05	5.92e-05	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—hematologic cancer	1.68e-05	5.92e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—CREBBP—hematologic cancer	1.68e-05	0.000371	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SMARCA4—hematologic cancer	1.67e-05	0.000369	CbGpPWpGaD
Zoledronate—Headache—Etoposide—hematologic cancer	1.67e-05	5.88e-05	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—hematologic cancer	1.66e-05	5.87e-05	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—hematologic cancer	1.66e-05	5.87e-05	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—hematologic cancer	1.66e-05	5.87e-05	CcSEcCtD
Zoledronate—Decreased appetite—Prednisone—hematologic cancer	1.66e-05	5.85e-05	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—hematologic cancer	1.66e-05	5.84e-05	CcSEcCtD
Zoledronate—Rash—Prednisolone—hematologic cancer	1.65e-05	5.84e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—UGT1A1—hematologic cancer	1.65e-05	0.000366	CbGpPWpGaD
Zoledronate—Dermatitis—Prednisolone—hematologic cancer	1.65e-05	5.84e-05	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.65e-05	5.83e-05	CcSEcCtD
Zoledronate—Malaise—Epirubicin—hematologic cancer	1.65e-05	5.82e-05	CcSEcCtD
Zoledronate—Fatigue—Prednisone—hematologic cancer	1.64e-05	5.8e-05	CcSEcCtD
Zoledronate—Headache—Prednisolone—hematologic cancer	1.64e-05	5.8e-05	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—hematologic cancer	1.64e-05	5.8e-05	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—hematologic cancer	1.64e-05	5.8e-05	CcSEcCtD
Zoledronate—Syncope—Epirubicin—hematologic cancer	1.64e-05	5.78e-05	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—hematologic cancer	1.64e-05	5.77e-05	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—hematologic cancer	1.64e-05	5.77e-05	CcSEcCtD
Zoledronate—Constipation—Prednisone—hematologic cancer	1.63e-05	5.76e-05	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—hematologic cancer	1.63e-05	5.74e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—CREBBP—hematologic cancer	1.62e-05	0.000357	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—hematologic cancer	1.62e-05	0.000357	CbGpPWpGaD
Zoledronate—Palpitations—Epirubicin—hematologic cancer	1.61e-05	5.7e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CRABP1—hematologic cancer	1.61e-05	0.000356	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC22A1—hematologic cancer	1.61e-05	0.000356	CbGpPWpGaD
Zoledronate—Confusional state—Methotrexate—hematologic cancer	1.61e-05	5.67e-05	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—hematologic cancer	1.61e-05	5.67e-05	CcSEcCtD
Zoledronate—Dizziness—Triamcinolone—hematologic cancer	1.6e-05	5.63e-05	CcSEcCtD
Zoledronate—Cough—Epirubicin—hematologic cancer	1.59e-05	5.63e-05	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—hematologic cancer	1.59e-05	5.63e-05	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—hematologic cancer	1.59e-05	5.63e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—SDC1—hematologic cancer	1.59e-05	0.000352	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—hematologic cancer	1.59e-05	0.000351	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—hematologic cancer	1.59e-05	0.000351	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—hematologic cancer	1.58e-05	0.00035	CbGpPWpGaD
Zoledronate—Convulsion—Epirubicin—hematologic cancer	1.58e-05	5.59e-05	CcSEcCtD
Zoledronate—Infection—Methotrexate—hematologic cancer	1.58e-05	5.59e-05	CcSEcCtD
Zoledronate—Nausea—Etoposide—hematologic cancer	1.58e-05	5.58e-05	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—hematologic cancer	1.58e-05	5.57e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisone—hematologic cancer	1.57e-05	5.55e-05	CcSEcCtD
Zoledronate—Asthenia—Betamethasone—hematologic cancer	1.57e-05	5.55e-05	CcSEcCtD
Zoledronate—Asthenia—Dexamethasone—hematologic cancer	1.57e-05	5.55e-05	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—hematologic cancer	1.57e-05	5.54e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—ALB—hematologic cancer	1.57e-05	0.000347	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALOX5—hematologic cancer	1.57e-05	0.000347	CbGpPWpGaD
Zoledronate—Nervous system disorder—Methotrexate—hematologic cancer	1.56e-05	5.52e-05	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—hematologic cancer	1.56e-05	5.52e-05	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—hematologic cancer	1.56e-05	5.51e-05	CcSEcCtD
Zoledronate—Gastrointestinal pain—Prednisone—hematologic cancer	1.56e-05	5.5e-05	CcSEcCtD
Zoledronate—Nausea—Prednisolone—hematologic cancer	1.56e-05	5.5e-05	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—hematologic cancer	1.56e-05	5.49e-05	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—hematologic cancer	1.56e-05	5.49e-05	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—hematologic cancer	1.56e-05	5.49e-05	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—hematologic cancer	1.55e-05	5.49e-05	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—hematologic cancer	1.55e-05	5.47e-05	CcSEcCtD
Zoledronate—Pruritus—Dexamethasone—hematologic cancer	1.55e-05	5.47e-05	CcSEcCtD
Zoledronate—Pruritus—Betamethasone—hematologic cancer	1.55e-05	5.47e-05	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—hematologic cancer	1.55e-05	5.46e-05	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.55e-05	5.45e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—LCK—hematologic cancer	1.54e-05	0.000341	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Methotrexate—hematologic cancer	1.54e-05	5.44e-05	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—hematologic cancer	1.54e-05	5.43e-05	CcSEcCtD
Zoledronate—Vomiting—Triamcinolone—hematologic cancer	1.53e-05	5.42e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CD—hematologic cancer	1.53e-05	0.000339	CbGpPWpGaD
Zoledronate—Malaise—Doxorubicin—hematologic cancer	1.52e-05	5.38e-05	CcSEcCtD
Zoledronate—Rash—Triamcinolone—hematologic cancer	1.52e-05	5.37e-05	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—hematologic cancer	1.52e-05	5.37e-05	CcSEcCtD
Zoledronate—Dermatitis—Triamcinolone—hematologic cancer	1.52e-05	5.37e-05	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—hematologic cancer	1.52e-05	5.36e-05	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—hematologic cancer	1.52e-05	5.36e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NUP98—hematologic cancer	1.52e-05	0.000336	CbGpPWpGaD
Zoledronate—Syncope—Doxorubicin—hematologic cancer	1.52e-05	5.35e-05	CcSEcCtD
Zoledronate—Urticaria—Prednisone—hematologic cancer	1.51e-05	5.35e-05	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—hematologic cancer	1.51e-05	5.34e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—ALB—hematologic cancer	1.51e-05	0.000334	CbGpPWpGaD
Zoledronate—Headache—Triamcinolone—hematologic cancer	1.51e-05	5.34e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—H3F3A—hematologic cancer	1.51e-05	0.000334	CbGpPWpGaD
Zoledronate—Abdominal pain—Prednisone—hematologic cancer	1.51e-05	5.32e-05	CcSEcCtD
Zoledronate—Body temperature increased—Prednisone—hematologic cancer	1.51e-05	5.32e-05	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—hematologic cancer	1.5e-05	5.31e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3R1—hematologic cancer	1.5e-05	0.000332	CbGpPWpGaD
Zoledronate—Diarrhoea—Betamethasone—hematologic cancer	1.5e-05	5.29e-05	CcSEcCtD
Zoledronate—Diarrhoea—Dexamethasone—hematologic cancer	1.5e-05	5.29e-05	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—hematologic cancer	1.49e-05	5.27e-05	CcSEcCtD
Zoledronate—Oedema—Epirubicin—hematologic cancer	1.49e-05	5.26e-05	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—hematologic cancer	1.49e-05	5.26e-05	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—hematologic cancer	1.49e-05	5.26e-05	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—hematologic cancer	1.49e-05	5.25e-05	CcSEcCtD
Zoledronate—Infection—Epirubicin—hematologic cancer	1.48e-05	5.23e-05	CcSEcCtD
Zoledronate—Cough—Doxorubicin—hematologic cancer	1.48e-05	5.21e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ADCY7—hematologic cancer	1.47e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA3—hematologic cancer	1.47e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCZ—hematologic cancer	1.47e-05	0.000325	CbGpPWpGaD
Zoledronate—Shock—Epirubicin—hematologic cancer	1.47e-05	5.18e-05	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—hematologic cancer	1.47e-05	5.17e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NUP214—hematologic cancer	1.46e-05	0.000324	CbGpPWpGaD
Zoledronate—Nervous system disorder—Epirubicin—hematologic cancer	1.46e-05	5.16e-05	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—hematologic cancer	1.46e-05	5.15e-05	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—hematologic cancer	1.46e-05	5.15e-05	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—hematologic cancer	1.46e-05	5.14e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.45e-05	5.13e-05	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—hematologic cancer	1.45e-05	5.11e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.45e-05	0.00032	CbGpPWpGaD
Zoledronate—Dizziness—Dexamethasone—hematologic cancer	1.45e-05	5.11e-05	CcSEcCtD
Zoledronate—Dizziness—Betamethasone—hematologic cancer	1.45e-05	5.11e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3R1—hematologic cancer	1.45e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALR—hematologic cancer	1.44e-05	0.000319	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Epirubicin—hematologic cancer	1.44e-05	5.09e-05	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—hematologic cancer	1.44e-05	5.09e-05	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—hematologic cancer	1.44e-05	5.08e-05	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—hematologic cancer	1.44e-05	5.08e-05	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—hematologic cancer	1.44e-05	5.08e-05	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—hematologic cancer	1.43e-05	5.06e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—MTR—hematologic cancer	1.43e-05	0.000317	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG2—hematologic cancer	1.43e-05	0.000317	CbGpPWpGaD
Zoledronate—Nausea—Triamcinolone—hematologic cancer	1.43e-05	5.06e-05	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—hematologic cancer	1.43e-05	5.05e-05	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.43e-05	5.05e-05	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—hematologic cancer	1.42e-05	5.02e-05	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—hematologic cancer	1.42e-05	5.02e-05	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—hematologic cancer	1.42e-05	5.02e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—PARP1—hematologic cancer	1.42e-05	0.000314	CbGpPWpGaD
Zoledronate—Somnolence—Methotrexate—hematologic cancer	1.42e-05	5e-05	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—hematologic cancer	1.41e-05	4.97e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ENO2—hematologic cancer	1.41e-05	0.000311	CbGpPWpGaD
Zoledronate—Hypersensitivity—Prednisone—hematologic cancer	1.4e-05	4.96e-05	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—hematologic cancer	1.4e-05	4.95e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—FBXW7—hematologic cancer	1.4e-05	0.000309	CbGpPWpGaD
Zoledronate—Hypotension—Epirubicin—hematologic cancer	1.39e-05	4.92e-05	CcSEcCtD
Zoledronate—Vomiting—Dexamethasone—hematologic cancer	1.39e-05	4.91e-05	CcSEcCtD
Zoledronate—Vomiting—Betamethasone—hematologic cancer	1.39e-05	4.91e-05	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—hematologic cancer	1.39e-05	4.91e-05	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—hematologic cancer	1.39e-05	4.89e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CB—hematologic cancer	1.38e-05	0.000306	CbGpPWpGaD
Zoledronate—Rash—Dexamethasone—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Rash—Betamethasone—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Dermatitis—Dexamethasone—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Dermatitis—Betamethasone—hematologic cancer	1.38e-05	4.87e-05	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.38e-05	4.86e-05	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—hematologic cancer	1.37e-05	4.85e-05	CcSEcCtD
Zoledronate—Headache—Betamethasone—hematologic cancer	1.37e-05	4.84e-05	CcSEcCtD
Zoledronate—Headache—Dexamethasone—hematologic cancer	1.37e-05	4.84e-05	CcSEcCtD
Zoledronate—Infection—Doxorubicin—hematologic cancer	1.37e-05	4.84e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—PTEN—hematologic cancer	1.37e-05	0.000303	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CXCR4—hematologic cancer	1.37e-05	0.000303	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HDAC2—hematologic cancer	1.37e-05	0.000303	CbGpPWpGaD
Zoledronate—Asthenia—Prednisone—hematologic cancer	1.37e-05	4.83e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTT1—hematologic cancer	1.36e-05	0.000302	CbGpPWpGaD
Zoledronate—Pain—Methotrexate—hematologic cancer	1.36e-05	4.81e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.36e-05	4.8e-05	CcSEcCtD
Zoledronate—Shock—Doxorubicin—hematologic cancer	1.36e-05	4.79e-05	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—hematologic cancer	1.35e-05	4.78e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—CD44—hematologic cancer	1.35e-05	0.000299	CbGpPWpGaD
Zoledronate—Thrombocytopenia—Doxorubicin—hematologic cancer	1.35e-05	4.77e-05	CcSEcCtD
Zoledronate—Pruritus—Prednisone—hematologic cancer	1.35e-05	4.76e-05	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—hematologic cancer	1.35e-05	4.76e-05	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—hematologic cancer	1.35e-05	4.75e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.34e-05	0.000297	CbGpPWpGaD
Zoledronate—Skin disorder—Doxorubicin—hematologic cancer	1.34e-05	4.73e-05	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—hematologic cancer	1.34e-05	4.73e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CB—hematologic cancer	1.34e-05	0.000295	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Doxorubicin—hematologic cancer	1.33e-05	4.71e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—CBL—hematologic cancer	1.33e-05	0.000295	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SDC1—hematologic cancer	1.33e-05	0.000295	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—hematologic cancer	1.33e-05	0.000295	CbGpPWpGaD
Zoledronate—Dyspnoea—Epirubicin—hematologic cancer	1.33e-05	4.69e-05	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—hematologic cancer	1.33e-05	4.68e-05	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—hematologic cancer	1.32e-05	4.64e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—hematologic cancer	1.31e-05	4.64e-05	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—hematologic cancer	1.31e-05	4.63e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—EP300—hematologic cancer	1.31e-05	0.000289	CbGpPWpGaD
Zoledronate—Diarrhoea—Prednisone—hematologic cancer	1.3e-05	4.61e-05	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.3e-05	4.6e-05	CcSEcCtD
Zoledronate—Nausea—Betamethasone—hematologic cancer	1.3e-05	4.59e-05	CcSEcCtD
Zoledronate—Nausea—Dexamethasone—hematologic cancer	1.3e-05	4.59e-05	CcSEcCtD
Zoledronate—Decreased appetite—Epirubicin—hematologic cancer	1.3e-05	4.58e-05	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—hematologic cancer	1.29e-05	4.55e-05	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.29e-05	4.55e-05	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—hematologic cancer	1.29e-05	4.54e-05	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.28e-05	0.000282	CbGpPWpGaD
Zoledronate—Pain—Epirubicin—hematologic cancer	1.28e-05	4.5e-05	CcSEcCtD
Zoledronate—Constipation—Epirubicin—hematologic cancer	1.28e-05	4.5e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.27e-05	0.000282	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HSP90AA1—hematologic cancer	1.27e-05	0.000281	CbGpPWpGaD
Zoledronate—Urticaria—Methotrexate—hematologic cancer	1.27e-05	4.47e-05	CcSEcCtD
Zoledronate—Dizziness—Prednisone—hematologic cancer	1.26e-05	4.45e-05	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—hematologic cancer	1.26e-05	4.45e-05	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—hematologic cancer	1.26e-05	4.45e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.26e-05	4.44e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.26e-05	0.000278	CbGpPWpGaD
Zoledronate—Insomnia—Doxorubicin—hematologic cancer	1.25e-05	4.41e-05	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—hematologic cancer	1.24e-05	4.37e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—CREBBP—hematologic cancer	1.24e-05	0.000273	CbGpPWpGaD
Zoledronate—Dyspnoea—Doxorubicin—hematologic cancer	1.23e-05	4.34e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—hematologic cancer	1.23e-05	4.34e-05	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—hematologic cancer	1.23e-05	4.33e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—STAT1—hematologic cancer	1.23e-05	0.000271	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.22e-05	4.31e-05	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—hematologic cancer	1.21e-05	4.29e-05	CcSEcCtD
Zoledronate—Vomiting—Prednisone—hematologic cancer	1.21e-05	4.28e-05	CcSEcCtD
Zoledronate—Rash—Prednisone—hematologic cancer	1.2e-05	4.24e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.2e-05	0.000266	CbGpPWpGaD
Zoledronate—Dermatitis—Prednisone—hematologic cancer	1.2e-05	4.24e-05	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—hematologic cancer	1.2e-05	4.23e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PTEN—hematologic cancer	1.2e-05	0.000265	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.19e-05	0.000264	CbGpPWpGaD
Zoledronate—Headache—Prednisone—hematologic cancer	1.19e-05	4.22e-05	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.19e-05	4.21e-05	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—hematologic cancer	1.19e-05	4.2e-05	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—hematologic cancer	1.18e-05	4.18e-05	CcSEcCtD
Zoledronate—Pain—Doxorubicin—hematologic cancer	1.18e-05	4.17e-05	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—hematologic cancer	1.18e-05	4.17e-05	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—hematologic cancer	1.18e-05	4.16e-05	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—hematologic cancer	1.18e-05	4.16e-05	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—hematologic cancer	1.17e-05	4.14e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—PIK3CD—hematologic cancer	1.17e-05	0.000259	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—hematologic cancer	1.16e-05	0.000256	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—hematologic cancer	1.15e-05	0.000255	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GRB2—hematologic cancer	1.15e-05	0.000254	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFA—hematologic cancer	1.14e-05	0.000253	CbGpPWpGaD
Zoledronate—Asthenia—Methotrexate—hematologic cancer	1.14e-05	4.04e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—EP300—hematologic cancer	1.14e-05	0.000252	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—hematologic cancer	1.14e-05	4.01e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NQO1—hematologic cancer	1.13e-05	0.000251	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD44—hematologic cancer	1.13e-05	0.000251	CbGpPWpGaD
Zoledronate—Nausea—Prednisone—hematologic cancer	1.13e-05	4e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—KITLG—hematologic cancer	1.13e-05	0.00025	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.13e-05	3.98e-05	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—hematologic cancer	1.13e-05	3.98e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.11e-05	0.000245	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3R1—hematologic cancer	1.11e-05	0.000245	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT5A—hematologic cancer	1.1e-05	0.000244	CbGpPWpGaD
Zoledronate—CA12—Metabolism—EP300—hematologic cancer	1.1e-05	0.000243	CbGpPWpGaD
Zoledronate—Hypersensitivity—Epirubicin—hematologic cancer	1.1e-05	3.88e-05	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—hematologic cancer	1.1e-05	3.87e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—CDKN2B—hematologic cancer	1.09e-05	0.000242	CbGpPWpGaD
Zoledronate—Body temperature increased—Doxorubicin—hematologic cancer	1.09e-05	3.85e-05	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—hematologic cancer	1.09e-05	3.85e-05	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—hematologic cancer	1.09e-05	3.85e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CYCS—hematologic cancer	1.07e-05	0.000237	CbGpPWpGaD
Zoledronate—Asthenia—Epirubicin—hematologic cancer	1.07e-05	3.78e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—HSP90AA1—hematologic cancer	1.07e-05	0.000236	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD86—hematologic cancer	1.06e-05	0.000234	CbGpPWpGaD
Zoledronate—Pruritus—Epirubicin—hematologic cancer	1.06e-05	3.72e-05	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—hematologic cancer	1.05e-05	3.72e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—HES1—hematologic cancer	1.04e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCOR1—hematologic cancer	1.04e-05	0.000229	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF1—hematologic cancer	1.03e-05	0.000227	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—hematologic cancer	1.02e-05	0.000226	CbGpPWpGaD
Zoledronate—Diarrhoea—Epirubicin—hematologic cancer	1.02e-05	3.6e-05	CcSEcCtD
Zoledronate—Hypersensitivity—Doxorubicin—hematologic cancer	1.02e-05	3.59e-05	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—hematologic cancer	1.01e-05	3.58e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—FOXO1—hematologic cancer	1.01e-05	0.000224	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFRB—hematologic cancer	1.01e-05	0.000223	CbGpPWpGaD
Zoledronate—Rash—Methotrexate—hematologic cancer	1e-05	3.55e-05	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—hematologic cancer	1e-05	3.54e-05	CcSEcCtD
Zoledronate—Headache—Methotrexate—hematologic cancer	9.98e-06	3.52e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—PDGFRA—hematologic cancer	9.93e-06	0.00022	CbGpPWpGaD
Zoledronate—Asthenia—Doxorubicin—hematologic cancer	9.9e-06	3.5e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—JAK1—hematologic cancer	9.9e-06	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCG—hematologic cancer	9.9e-06	0.000219	CbGpPWpGaD
Zoledronate—Dizziness—Epirubicin—hematologic cancer	9.86e-06	3.48e-05	CcSEcCtD
Zoledronate—Pruritus—Doxorubicin—hematologic cancer	9.76e-06	3.45e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—PIK3CA—hematologic cancer	9.66e-06	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.59e-06	0.000212	CbGpPWpGaD
Zoledronate—Vomiting—Epirubicin—hematologic cancer	9.48e-06	3.35e-05	CcSEcCtD
Zoledronate—Nausea—Methotrexate—hematologic cancer	9.47e-06	3.34e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTP1—hematologic cancer	9.45e-06	0.000209	CbGpPWpGaD
Zoledronate—Diarrhoea—Doxorubicin—hematologic cancer	9.44e-06	3.33e-05	CcSEcCtD
Zoledronate—Rash—Epirubicin—hematologic cancer	9.4e-06	3.32e-05	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—hematologic cancer	9.4e-06	3.32e-05	CcSEcCtD
Zoledronate—Headache—Epirubicin—hematologic cancer	9.34e-06	3.3e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—MTHFR—hematologic cancer	9.17e-06	0.000203	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.14e-06	0.000202	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HLA-A—hematologic cancer	9.14e-06	0.000202	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—hematologic cancer	9.14e-06	0.000202	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—hematologic cancer	9.13e-06	3.22e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ABCB1—hematologic cancer	8.95e-06	0.000198	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFB—hematologic cancer	8.92e-06	0.000197	CbGpPWpGaD
Zoledronate—Nausea—Epirubicin—hematologic cancer	8.86e-06	3.13e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—PTEN—hematologic cancer	8.82e-06	0.000195	CbGpPWpGaD
Zoledronate—Vomiting—Doxorubicin—hematologic cancer	8.77e-06	3.1e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—TSC2—hematologic cancer	8.72e-06	0.000193	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—hematologic cancer	8.7e-06	3.07e-05	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—hematologic cancer	8.69e-06	3.07e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTM1—hematologic cancer	8.68e-06	0.000192	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOR1—hematologic cancer	8.68e-06	0.000192	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—hematologic cancer	8.65e-06	3.05e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CA—hematologic cancer	8.44e-06	0.000187	CbGpPWpGaD
Zoledronate—CA2—Metabolism—EP300—hematologic cancer	8.41e-06	0.000186	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR3—hematologic cancer	8.39e-06	0.000186	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—hematologic cancer	8.2e-06	2.89e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CA—hematologic cancer	8.14e-06	0.00018	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BAD—hematologic cancer	7.95e-06	0.000176	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—hematologic cancer	7.89e-06	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOTCH1—hematologic cancer	7.87e-06	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD80—hematologic cancer	7.71e-06	0.000171	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KIT—hematologic cancer	7.7e-06	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—hematologic cancer	7.68e-06	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTPN11—hematologic cancer	7.57e-06	0.000167	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CREB1—hematologic cancer	7.33e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—hematologic cancer	7.24e-06	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6R—hematologic cancer	7.15e-06	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CREBBP—hematologic cancer	7.14e-06	0.000158	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—hematologic cancer	6.9e-06	0.000153	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K1—hematologic cancer	6.81e-06	0.000151	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—hematologic cancer	6.77e-06	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.76e-06	0.00015	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—hematologic cancer	6.65e-06	0.000147	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF2—hematologic cancer	6.48e-06	0.000143	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—hematologic cancer	6.45e-06	0.000143	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3R1—hematologic cancer	6.39e-06	0.000141	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—hematologic cancer	6.22e-06	0.000138	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JAK2—hematologic cancer	6.21e-06	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—hematologic cancer	6.06e-06	0.000134	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CREBBP—hematologic cancer	5.98e-06	0.000132	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—hematologic cancer	5.9e-06	0.000131	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—hematologic cancer	5.9e-06	0.000131	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD4—hematologic cancer	5.89e-06	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—hematologic cancer	5.67e-06	0.000125	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—hematologic cancer	5.6e-06	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—hematologic cancer	5.54e-06	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3R1—hematologic cancer	5.35e-06	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—hematologic cancer	5.11e-06	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—hematologic cancer	5.1e-06	0.000113	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—hematologic cancer	5.08e-06	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—hematologic cancer	4.94e-06	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EP300—hematologic cancer	4.86e-06	0.000108	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—hematologic cancer	4.73e-06	0.000105	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—hematologic cancer	4.56e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRAS—hematologic cancer	4.55e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—hematologic cancer	4.36e-06	9.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—hematologic cancer	4.27e-06	9.44e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—hematologic cancer	4.24e-06	9.37e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—hematologic cancer	4.23e-06	9.35e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—EP300—hematologic cancer	4.07e-06	9.01e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—hematologic cancer	3.92e-06	8.66e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—hematologic cancer	3.6e-06	7.96e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—hematologic cancer	3.33e-06	7.36e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—hematologic cancer	3.19e-06	7.04e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—hematologic cancer	3.01e-06	6.66e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—hematologic cancer	2.94e-06	6.5e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—hematologic cancer	2.46e-06	5.44e-05	CbGpPWpGaD
